Production (Stage)
WELL Health Technologies Corp.
WELL.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 705.26M | 666.07M | 698.00M | 665.86M | 615.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 705.26M | 666.07M | 698.00M | 665.86M | 615.40M |
| Cost of Revenue | 433.23M | 406.07M | 393.13M | 373.04M | 333.44M |
| Gross Profit | 272.03M | 260.00M | 304.87M | 292.82M | 281.96M |
| SG&A Expenses | 231.90M | 225.73M | 229.16M | 224.50M | 218.05M |
| Depreciation & Amortization | 54.06M | 52.72M | 50.06M | 48.77M | 46.57M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 719.18M | 684.51M | 672.35M | 646.30M | 598.06M |
| Operating Income | -13.92M | -18.44M | 25.65M | 19.56M | 17.34M |
| Income Before Tax | -37.01M | 1.45M | 63.13M | 114.51M | 30.37M |
| Income Tax Expenses | -15.10M | -16.06M | -1.85M | -2.67M | 168.80K |
| Earnings from Continuing Operations | -21.90 | 17.50 | 64.99 | 117.18 | 30.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.28M | 3.47M | -14.28M | -12.62M | -11.56M |
| Net Income | -19.63M | 20.98M | 50.71M | 104.57M | 18.63M |
| EBIT | -13.92M | -18.44M | 25.65M | 19.56M | 17.34M |
| EBITDA | 28.47M | 22.61M | 67.96M | 60.57M | 56.15M |
| EPS Basic | -0.08 | 0.08 | 0.21 | 0.43 | 0.08 |
| Normalized Basic EPS | -0.16 | -0.17 | -0.08 | -0.08 | -0.08 |
| EPS Diluted | -0.11 | 0.06 | 0.19 | 0.41 | 0.07 |
| Normalized Diluted EPS | -0.16 | -0.16 | -0.08 | -0.08 | -0.08 |
| Average Basic Shares Outstanding | 969.16M | 961.80M | 978.39M | 967.69M | 957.07M |
| Average Diluted Shares Outstanding | 985.75M | 988.50M | 1.01B | 994.39M | 967.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |